1. Advances in oncolytic adenovirus therapy for pancreatic cancer
   Callum Baird Nattress et al, 2018, Cancer Letters CrossRef
2. Challenges of NK cell-based immunotherapy in the new era
   Fang Fang et al, 2018, Frontiers of Medicine CrossRef
3. Bioengineered tissue models for the development of dynamic immuno-associated tumor models and high-throughput immunotherapy cytotoxicity assays
   Amir Seyfoori et al, 2021, Drug Discovery Today CrossRef
4. Cellular therapy: Adoptive immunotherapy with expanded natural killer cells
   Dean A. Lee, 2019, Immunological Reviews CrossRef
5. Development of an antibody-ligand fusion protein scFvCD16A-sc4-1BBL in Komagataella phaffii with stimulatory activity for Natural Killer cells
   Yangyang Li et al, 2023, Microbial Cell Factories CrossRef
6. NK cell-based immunotherapy for cancer
   Fang Fang et al, 2017, Seminars in Immunology CrossRef
7. Expanding the Spectrum of Adenoviral Vectors for Cancer Therapy
   Jian Gao et al, 2020, Cancers CrossRef
8. A Two-Phase Expansion Protocol Combining Interleukin (IL)-15 and IL-21 Improves Natural Killer Cell Proliferation and Cytotoxicity against Rhabdomyosarcoma
   Juliane Wagner et al, 2017, Frontiers in Immunology CrossRef
9. Shaping the Tumor Stroma and Sparking Immune Activation by CD40 and 4-1BB Signaling Induced by an Armed Oncolytic Virus
   Emma Eriksson et al, 2017, Clinical Cancer Research CrossRef
10. Obtaining Gene-Modified HLA-E-Expressing Feeder Cells for Stimulation of Natural Killer Cells
    Nadezhda A. Alekseeva et al, 2024, Pharmaceutics CrossRef
11. Immunodeficiency and EBV-induced lymphoproliferation caused by 4-1BB deficiency
    Mohammed F. Alosaimi et al, 2019, Journal of Allergy and Clinical Immunology CrossRef
12. Phase 1 clinical trial using mbIL21 ex vivo–expanded donor-derived NK cells after haploidentical transplantation
    Stefan O. Ciurea et al, 2017, Blood CrossRef
13. An acetylated derivative of vitexin halts MDA-MB-231 cellular progression and improves its immunogenic profile through tuning miR- 20a-MICA/B axis
    Aya R. Awad et al, 2021, Natural Product Research CrossRef
14. CD137 (4-1BB)-Based Cancer Immunotherapy on Its 25th Anniversary
    Ignacio Melero et al, 2023, Cancer Discovery CrossRef
15. Addressing Natural Killer Cell Dysfunction and Plasticity in Cell-Based Cancer Therapeutics
    Kassandra M. Coyle et al, 2023, Cancers CrossRef
16. Immune checkpoints on T and NK cells in the context of HBV infection: Landscape, pathophysiology and therapeutic exploitation
    Lucile Dumolard et al, 2023, Frontiers in Immunology CrossRef
17. Breaking down barriers: The potential of smarter CAR‐engineered NK cells against solid tumors
    Muhammad B. Khawar et al, 2023, Journal of Cellular Biochemistry CrossRef
18. A Critical Role of Culture Medium Selection in Maximizing the Purity and Expansion of Natural Killer Cells
    Neele Kusch et al, 2024, Cells CrossRef
19. CD40 stimulation via CD40 ligand enhances adenovirus‐mediated tumour immunogenicity including ‘find‐me’, ‘eat‐me’, and ‘kill‐me’ signalling
    Sedigheh Naseri et al, 2024, Journal of Cellular and Molecular Medicine CrossRef
20. CAR NK Cells: The Future Is Now
    Martin J. Raftery et al, 2023, Annual Review of Cancer Biology CrossRef
21. Feeder-Cell-Free and Serum-Free Expansion of Natural Killer Cells Using Cloudz Microspheres, G-Rex6M, and Human Platelet Lysate
    Christopher D. L. Johnson et al, 2022, Frontiers in Immunology CrossRef
22. Natural killer cell therapy for hematologic malignancies: successes, challenges, and the future
    Margaret G. Lamb et al, 2021, Stem Cell Research & Therapy CrossRef
23. iPSC‐derived NK cells with site‐specific integration of CAR19 and IL24 at the multi‐copy rDNA locus enhanced antitumor activity and proliferation
    Yuxuan Zhang et al, 2024, MedComm CrossRef
24. New Orders to an Old Soldier: Optimizing NK Cells for Adoptive Immunotherapy in Hematology
    Mehmet Gunduz et al, 2021, Biomedicines CrossRef
25. Comparison of the different anti-CD16 antibody clones in the activation and expansion of peripheral blood NK cells
    Jinho Kim et al, 2023, Scientific Reports CrossRef